Inside Investor Relations


Bayer to de-list from LSE

Comments (0) | 26 Sep 2011 | RatingRating (-1 to +1): 0.0 | Print

German group says cost and effort of maintaining listing is too much


Bayer, the German chemicals and pharmaceutical company, has announced plans to de-list from the London Stock Exchange (LSE).

The DAX 30 constituent, which originally listed in London in 1961, says the action is being taken due to its low trading volume at the LSE and the administrative costs and effort ...

Register now to read the rest of this article! Registration is free and you will be able to read five articles every month.

Become a subscriber for unlimited access.

Read More About Topics

More on sectors in this article

More on companies in this article


The OTCQX® marketplace is the intelligent marketplace and premier tier of the OTC securities market, providing investors with an objective measure to distinguish the best OTC-traded companies. Investor-focused companies use the OTCQX platform to offer investors transparent trading, superior information, and easy access through a regulated U.S. broker-dealer of their choice. OTCQX offers companies a suite of customized services and a community of professional advisors that guide them as they grow their companies.

To learn more, visit us at www.otcmarkets.com.


Featured Articles

Print magazine
All the articles from the May edition of
IR magazine
More

Technology
Walmart launches a new IR app plus
a video-heavy annual report
More

IR societies
How the Netherlands’ IR association
has promoted IR for 20 years
More